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854-1 High Prevalence of Impaired Glucose Metabolism in 
Patients With Idiopathic Dilated Cardiomyopathy 
Aamer H. Jamali. Ronald M. Witteles, W. H. Wilson Tang, James W. Chu, Gerald M. 
Reaven, Michael B. Fowler, Stanford University School of Medicine, Stanford, California. 
Background: The pathogenesis of idiopathic dilated cardiomyopathy (IDC) is poody 
understood. Reversible metabolic derangements uch as insulin resistance (IR) have 
recently been described as potential causes of reduced contractility. Indeed, treatment of 
IR has been shown to slow the progression of systolic dysfunction in animal models. 
Because patients with IR have a high frequency of impaired glucose metabolism, we 
sought to establish the prevalence of impaired glucose metabolism in IOC. 
Methods: The records of 230 consecutive medically stable outpatients referred for trans- 
plant evaluation to the Stanford University Cardiomyopathy Clinic were reviewed, of 
which 104 had IDC. Twenty of these patients had diabetes mellitus (DM) and were 
excluded from further testing. Forty-one patients were unable to be contacted or declined 
testing. The remaining 43 patients underwent fasting metabolic measurements and oral 
glucose tolerance tasting. 
Reaulta: Of the 43 patients tested, 21 (49%) exhibited impaired glucose metabolism, 
manifested by either impaired glucose tolerance (n=12), impaired fasting glucose (n=3), 
or previously undiagnosed DM (n=6) as defined by the American Diabetes Association. 
There were no significant differences in age, gender, race, heart failure class, family his- 
tory of DM, body mass index, or history of hypertension between the patient groups. 
Conclualona: This study demonstrates a strikingly high prevalence of impaired glucose 
metabolism in non-DM patients with IDC, in addition to a high prevalence of previously 
diagnosed DM. Patients with occult glucose dysmetabolism could not be distinguished 
on the basis of historical details or anthropometric measurements. These patients may 
comprise a subgroup in which disease progression can be delayed or reversed by cor- 
rection of the metabolic derangement. Thus, our group recommends the routine testing 
of all patients with IDC for impaired glucose metabolism. 
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854-2 Carvedilol Is More Potent Than Candseartan in the 
Treatment of Cardiac Dysfunction From Diabetes 
Tetsuva Havashi, Tatsuhiko Mori, Sakiko Endo, Hireaki Shimomura, Koichi Sohmiya, 
Yasushi Kitaura, Osaka Medical College, Takatsuki, Japan. 
Oxidative stress in diabetes might contribute to cardiomyocyte dysfunction and induce 
the stress protein heine oxygenase (HO)-I. The OLETF (Otsuka Long-Evans Tokushima 
Fatty) rats at 40 weeks of age (n=40), exhibiting non-insulin dependent diabetes mellitus, 
were divided into three groups and treated with candesartan 0.2 mg/kg/day (ARB), 
carvedilol 10 mg/kg/day (B) or vehicle (V) for 4 weeks. In all animals, including control 
LETO rats (n=20), ultrastructure and HO-1 in the myocardium and TBARS (thioberbituric 
acid-reactive substances) in the plasma were studied. The OLETF rats caused left ven- 
thcular (LV) dysfunction, severe myocardial degeneration, and increased HO-1 and 
TBARS, compared to LETO rats. Though LV dysfunction was improved by either treat- 
ment, histological changes were minimal and oxidative stress was significantly reduced 
only in rats with B (Table). Conclusion: Carvedilol was more potent for reduction of oxida- 
tive stress, and was more protective for heart than candesartan. Thus, reduction of oxi- 
dative stress should be the major target in the treatment of cardiac dysfunction from 
diabetes. 
Table. Summary of Hemodynamic Data and TBARS 
Hw/Bw HR LVsys LVed max dP/dt min dP/dt TBARS 
L 2.5+/-0.1 402+/-40 96+/-4 6+/-2 3496+/-750 3543+/-285 2.9+/-0.6 
O+V 2.8+/-0.3 259+/-64* 113+/-7" 11+/-2" 2941+/-269 2358+/-224* 8.2+/-1.9" 
O+ARB 2.5+/-0.1 294+/-53 77+/-5** 7+/-2** 3240+/-746 3420+/-746** 7.6+/-1.3 
O+B 2.5+/-0.1 211+/-17 119+/-8" 7+/-2** 4275+/-512"'4275+/-512"'4.8+/-1.2"* 
L; LETO, O+V; OLETF+vehicle, O+ARB; given candesertan, O+B; given carvedilol, 
Hw/Bw; heart/body weight ratio (mg/g), HR; heart rate (bpm), LVsys and LVed; LV sys- 
tolic and end-diastolic pressure (mmHg), max and rain dP/dt; peak positive and nega- 
tive dP/dt (mmHg/sec), TBARS; nM/ml. Values are mean +/- SD. *p<0.05 vs. LETO, 
**p<0.05 vs. OLETF. 
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854-3 Myocardial Collagen Turnover in Hypertrophic 
Cardlomyopathy: Comparison to Healthy Subjects 
R~ffaalla Lombardi, Sandro Betocchi, Maria Angela Losi, Quidno Ciampi, Cado G. 
Tocchefti, EIpidio Pszzella, Filippo Finizio, Mariano Aversa, Marianna Miranda, Veronica 
De Crescanzo, Massimo Chiariello, Department of Clinical Medicine, Cardivascular and 
Immunological Science, University of Naples, Naples, Italy. 
BACKGROUND LV hypertrophy and fibrosis are characteristics of hypertrophic ardi- 
omyopathy (HCM). We assessed the impact of collagen turnover on LV anatomy and 
function in HCM. METHODS We studied 29 HCM patients (36±9 years) and 10 age and 
sex-matched controls. We assessed cardiac fibrosis by RIA measurement of serum con- 
centrations of: procollagsn III N-terminal propeptide (PtilNP), index of collagen III synthe- 
sis; procollagen I C-terminal propeptide (PICP) and collagen I C-terminal telopeptide 
(ICTP), indexes of collagen I synthesis and degradation. They were In-transformed. LV 
hypertrophy was quantified by the Wigle's score. Diastolic function was evaluated by the 
duration difference in antegrada (mitral) and retrograde (pulmonary vein) A wave (Adiff). 
RESULTS PIIINP and ICTP were higher in HCM than in controls (1.3(.4) vs .9(.3) ng/ml, 
p=.002; 1.0(.4) vs .8(.2) ng/ml, p=.048) and inversely related to age in HCM (r=-.424, 
p=.022; r=-.651, p<.001). PICP and ICTP were directly related to one another (r=.395, 
p=.013). PtlINP was inversely related to LV end-diastolic dimension, while ICTP was 
directly related to Wigle's score (Figure). PIIINP and ICTP were inversely related to Adiff 
(r=-.393, p=.035; and r=-.584, p<.001). CONCLUSIONS In HCM patients collagen 
metabolism is more active than in controls and it decreases with age. Collagen I degra- 
dation parallels synthesis (steady state). Collagen turnover influences degree of hyper- 
trophy, cavity size and passive diastolic properties. 
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854-4 Does Isolated Bundle Branch Block Cause Left 
Ventricular Remodeling? 
Seuna-Joon Lee, Eric J. Putz, Elyss Foster, Teresa DeMarco, Leslie A. Saxon, University 
of California San Francisco, San Francisco, California. 
Background: Population studies have identified the presence of bundle branch block 
(BBB) as an independent dsk factor for total mortality in pts with known cardiac disease. 
it is unknown how chronic ventricuiar dyssynchreny resulting solely from conduction 
delay impacts ventricutar function. We performed a retrospective pilot study to determine 
if chronic, isolated BBB affects echocardiographic measures of progressive ventricular 
remodeling. 
Methods: Patients were consecutively identified from the UCSF ECG database with 
QRS duration >=120ms. Retrospective chart review was conducted in 126 pts 
(age=71.9±16.5 yrs; Female=49%). Pts were excluded based on presence of coexisting 
heart disease. Those pts with isolated BBB and without identifiable cardiac disease who 
had serial echocardiograms for comparison compdsed the study population. 
Results: Of 126 pts with QRS>=120ms, 69 pts (55%) had coexisting cardiac disease 
versus 57 (45%) without identifiable cardiac disease. Of the 57 pts, 22 (39%) pts had 
sequential measures of left ventricular (LV) function available for review (Table). LV ejec- 
tion fraction (LVEF) was reduced by 19.5% in the isolated LBBB cohort (p=0.0125) ver- 
sus 3.1% reduction in isolated RBBB cohort (p=0.4106). 
Conclusion: In a subset of pts, LBBB often precedes LV remodeling. Our pilot data sug- 
gests isolated LBBB may be the earliest manifestation of a progressive subclinical cardi- 
omyopathic process and BBB induced LV dyssynchreny may itself trigger ventricular 
remodeling. 
No LVEF change (%) Reduction in LVEF (%) Mean F/U (months) 
All pts n=22 14 (64%) 8 (36%) 64.1 ±50.8 
LBBB n=12 5 (42%) 7 (58%) 55.8±36.96 
RBBB n=10 9 (90%) 1 (10%) 73.9¢64.4 
